_._ L.---l Alcohol Use Disorder'': b (490) Speciftj current severity: (FiO.10) Mild (F10.20) (1=10.20)
|
|
|
- Stephany Stevenson
- 6 years ago
- Views:
Transcription
1 DSM-5 Classification xxv Substance-Related and Addictive.".: Disorders -- (481) The following specifiers and note apply to Substance-Related and Addictive Disorders where indicated: aspecify if: In early remission, In sustained remission bspecify if: In a controlled environment' cspeciftj if: With perceptual dthe rcd-io-cm code indicates the comorbid presence of a moderate or severe substance use disorder, which must be present in order to apply the code for substance withdrawal. Substance-Related Disorders (483) Alcohol-Related Disorders (490) _._ L.---l Alcohol Use Disorder'': b (490) Speciftj current severity: (FiO.10) (F10.20) (1=10.20) L._) (F10.129) (F10.229) (F10.929) L _l (FiO.239) (F10.232) (_.---l {Fi0.ge} Alcohol Intoxication (497) Caffeine-Related Disorders (503) Alcohol Withdrawal'< d (499) With perceptual Other Alcohol-Induced Disorders (502) Unspecified Alcohol-Related Disorder (503) (F15.929) Caffeine Intoxication (503) (F15.93) Caffeine Withdrawal (506) _,._ L.-1 Other Caffeine-Induced Disorders (508) (Fi5.99) Unspecified Caffeine-Related Disorder (509) Cannabis-Related Disorders (509) _._ L.---l Cannabis Use Disorder= b (509) (F'l2.10) {F12.20} (F12.20)
2 xxvi DSM-5 Classification (_.--> (F12. i29) (Fi2.229) (F12.929) Cannabis Intoxication? (516) With perceptual (Fi2.122) (F12.222) (Fi2.922) (f12.288) Cannabis Withdrawal d (517) L.-> Other Cannabis-Induced Disorders (519) (F"i2.99) Unspecified Cannabis-Related Disorder (519) Hallucinogen-Related Disorders (520) _._ L.-> Phencyclidine Use Disorder" b (520) (FiG.10) (F16.20) (F16.20) -'- (-'--> (!Fi6.10) (F16.20) (F16.20) Other Hallucinogen Use Disorder": b (523) Specify the particular hallucinogen {_.-> Phencyclidine Intoxication (527) (F16.129) (F16.229) (F16.929) L._} Other Hallucinogen Intoxication (529) (f16.129) (F16.229) (Fi6.929) (Fi6.983) Hallucinogen Persisting Perception Disorder (531) L.--> Other Phencyclidine-Induced Disorders (532) L.-----> Other Hallucinogen-Induced Disorders (532) (F16.99) Unspecified Phencyclidine-Related Disorder (533) (l=16.99) Unspecified Hallucinogen-Related Disorder (533) Inhalant-Related Disorders (533) _._ {_._> Inhalant Use Disorder'v b (533) (F18.10) Specify the particular inhalant. Speciftj current severity:
3 DSM-5 Classification xxvii (F18.20) (Fi8.20) {_.-> Inhalant Intoxication (538) (F18.129) (F18.229) (F18.929) <--'-} (F18.99) -._ L.-.J Opioid-Related Disorders (540) {F11. "i0) (F"l1.20) (F11.20) L.-l (F11:i29) (F11.229) (F11.929) (F11.122) (1=11.222) (F'11.922) (F11.23) (F11.99) Other Inhalant-Induced Disorders (540) Unspecified Inhalant-Related Disorder (540) Opioid Use Disorder" (541) Specify if: On maintenance therapy, In a controlled environment Specifij current severity: Opioid Intoxication" (546) With perceptual Opioid Withdrawal d (547) Other Opioid-Induced Disorders (549) Unspecified Opioid-Related Disorder (550) Sedative-, Hypnotic-, or Anxiolytic-Related Disorders (550) _._ {_.--1 Sedative, Hypnotic, or Anxiolytic Use Disorder'" b (550) (F13.10) (f13.20) (f13.20) L._} (1=13.129) (1F13.229) (F13.929) L.-.-J (F13.239) (f13.232) Sedative, Hypnotic, or Anxiolytic Intoxication (556) Sedative, Hypnotic, or Anxiolytic Withdrawal": d (557) With perceptual
4 c xxviii DSM-5 Classification Other Sedative-, Hypnotic-, or Anxiolytic-Induced Disorders (560) 292,9 (FI3.99) Unspecified Sedative-, Hypnotic-, or Anxiolytic-Related Disorder (560) Stimulant-Related Disorders (561) L.-l Stimulant Use Disorder+ b (561) _,_ (F15.10) 305,60 {Fi 4. io} (F15.10) _,_ i~.-> (F14,20) _._ (F14.20) (1=15.20) L.-l {_.--l {F15.129} (F15.229) (1=15.929) L.-i (F14.129) (F14.229) (F14.929) f_._} (F15. "l22) (F15.222) (F15.922) \_.-l (F14.i22) (F14,222) (F14.922) L --l (F15.23) (F14.23) -- L -i Stimulant Intoxication" (567) SpeciftJ the specific intoxicant Amphetamine or other stimulant, perceptual, Amphetamine or other stimulant, With perceptual, With perceptual Stimulant Withdrawal d (569) Specify the specific substance causing the withdrawal syndrome Amphetamine or other stimulant Other Stimulant-Induced Disorders (570)
5 -----~ , DSM-5 Classification xxix <_.---> (F15.99) {F14.99} Unspecified Stimulant-Related Disorder (570) Amphetamine or other stimulant Tobacco-Related Disorders (571) -'- < (Z72.0) (FH.200) (F17.200} (f17.203) {-'-> (f17.209) Tobacco Use Disorder" (571) Specifij if: On maintenance therapy, In a controlled environment Tobacco Withdrawal d (575) Other Tobacco-Induced Disorders (576) Unspecified Tobacco-Related Disorder (577) Other (or Unknown) Substance-Related Disorders (577) (_,-1 Other (or Unknown) Substance Use Disorder'" b (577) (F19.10) (F19.20) (F19.20) L._} (f19.129) (F19.22S) {Fi9.929} (F19.239) (Fi9.99) Other (or Unknown) Substance Intoxication (581) Other (or Unknown) Substance Withdrawal d (583) Other (or Unknown) Substance-Induced Disorders (584) Unspecified Other (or Unknown) Substance-Related Disorder (585) Non-Substance-Related Disorders (585) (&=63.0) Gambling Disorder" (585) Specifij if: Episodic, Persistent Specifij current severity:,, Neurocognitive Disorders (591) jj -' L -J {_.-i (F05) Delirium (596) "Note: See the criteria set and corresponding recording procedures for substance-specific codes and ICD-9-CM and lcd-lo-cm coding. Specify whether: Substance intoxication delirium" Substance withdrawal delirium= Medication-induced delirium" Delirium due to another medical condition
PRACTICE ALERT. New ICD Code Changes. Mirean Coleman, LICSW, CT Clinical Manager. December 2017
PRACTICE ALERT New ICD Code Changes Mirean Coleman, LICSW, CT Clinical Manager December 2017 Each year the National Center for Health Statistics (NCHS), releases new, updated, or deleted codes for the
The Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5) دکتر راد گودرزی
The Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5) 1 Expanded to include Gambling Disorder Cannabis Withdrawal and Caffeine Withdrawal are new disorders Caffeine Withdrawal
DSM-5 UPDATE. Supplement to DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS, FIFTH EDITION
DSM-5 UPDATE Supplement to DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS, FIFTH EDITION October 2017 DSM-5 Update October 2017 Supplement to Diagnostic and Statistical Manual of Mental Disorders,
PerformCare Provider Network Scott Daubert PhD, VP Provider Network & Account Management. AD ICD-10-CM Frequently Asked Questions
Provider Notice To: From: PerformCare Provider Network Scott Daubert PhD, VP Provider Network & Account Management Date: April 23, 2015 Subject: AD 15 105 ICD-10-CM Frequently Asked Questions The Centers
Substance Use Disorders
Substance Use Disorders Substance Use Disorder This is a 15 minute webinar session for CNC physicians and staff CNC holds webinars monthly to address topics related to risk adjustment documentation and
INDIANA HEALTH COVERAGE PROGRAMS
INDIANA HEALTH COVERAGE PROGRAMS PROVIDER CODE TABLES Division of Mental Health and Addiction (DMHA) Behavioral and Primary Healthcare Coordination (BPHC) Codes Note: Due to possible changes in Indiana
DSM-5 Table of Contents
DSM-5 Table of Contents DSM-5 Classification Preface Section I: DSM-5 Basics Introduction Use of DSM-5 Cautionary Statement for Forensic Use of DSM-5 Section II: Essential Elements: Diagnostic Criteria
*Many of these DSM 5 Diagnoses might also be used to argue for eligibility using Other Health Impaired Criteria
Handout 2: DSM 5 Diagnoses that May be Associated with One or More of the Five ED Characteristics* 1. An inability to learn that cannot be explained by intellectual, sensory, or health factors. a) Selective
INDIANA HEALTH COVERAGE PROGRAMS
INDIANA HEALTH COVERAGE PROGRAMS PROVIDER CODE TABLES Medicaid Rehabilitation Option (MRO) Services Codes Note: Due to possible changes in Indiana Health Coverage Programs (IHCP) policy or national coding
Prescription Drug Monitoring and Toxicology ICD-10-CM. resource guide. Provided as a service of Quest Diagnostics. 1 ICD-10-CM Resource Guide
Prescription Drug Monitoring and Toxicology ICD-10-CM resource guide Provided as a service of Quest Diagnostics 1 ICD-10-CM Resource Guide Table of contents About ICD-10 3 Pain Management: Top Mappings
Table of substance use disorder diagnoses:
Table of substance use disorder diagnoses: ICD-9 Codes Description 291 Alcohol withdrawal delirium 291.3 Alcohol-induced psychotic disorder with hallucinations 291.4 Idiosyncratic alcohol intoxication
ICD-10-CM Resource Guide
Prescription Drug Monitoring and Toxicology ICD-10-CM Resource Guide Provided as a service of Quest Diagnostics 1 ICD-10-CM Resource Guide Table of Contents About ICD-10 3 Pain Management: Top Mappings
The Virtual En-psych-lopedia by Dr. Bob. DSM-IV Diagnoses and Codes, Alphabetical Listing
The Virtual En-psych-lopedia by Dr. Bob DSM-IV Diagnoses and Codes, Alphabetical Listing DSM-5 listings: alphabetical, by diagnosis numerical, by ICD-9-CM and ICD-10-CM code This is just an alphabetical
STATE OF WASHINGTON ACCESS TO CARE STANDARDS
STATE OF WASHINGTON ACCESS TO CARE STANDARDS FOR BEHAVIORAL HEALTH ORGANIZATIONS Effective: 01 April 2016 NORTH SOUND BHO-THERAPEUTIC-MEDICAID-16-18 1 P a g e INTRODUCTION AND SCOPE The statewide Access
12/26/ Fear of the unknown prevents one from embracing the future.
Fear of the unknown prevents one from embracing the future. 12/26/2017 1 12/26/2017 2 The American Psychiatric Association first published a predecessor to the DSM in 1844. It was a statistical classification
Profile of PAES Recipients and Factors That Influence PAES Outcomes
` San Francisco Department of Human Services County Adult Assistance Programs Personal Assisted Employment Services Program Profile of PAES Recipients and Factors That Influence PAES Outcomes Analysis
Pinellas County Mental Health & Substance Abuse Data Collaborative
Pinellas County Mental Health & Substance Abuse Data Collaborative MEMORANDUM TO: FROM: Pinellas County Mental Health & Substance Abuse Data Collaborative Members Diane Haynes, PSRDC, MHLP, FMHI, USF DATE:
Today s Presenter 4/22/2015. ICD-10-CM Documentation and Diagnosis: Behavioral Health. By Tammy Jones, CPC, COC
ICD-10-CM Documentation and Diagnosis: Behavioral Health By Tammy Jones, CPC, COC Today s Presenter Tammy Jones, CPC, COC SVA Healthcare Services, LLC 608.826.2147 jonest@sva.com 1 ICD-10 Documentation
Substance Use and Addictive Disorders
Key Dates TU Feb 14 Unit 8 147-end and Unit 9; MW Ch 8 Jeffrey and Ch 10 Diana TH Feb 16 Unit 10; MW Ch 11 Theodore B TU Feb 21 Monday class schedule TH Feb 23 Begin Dimensions-Cognition, Units IIC and
MEDICARE LOCAL COVERAGE DETERMINATION COMMONLY USED DIAGNOSIS CODES
MEDICARE LOCAL COVERAGE DETERMINATION COMMONLY USED DIAGNOSIS CODES Urine drug testing (UDT) provides objective information to assist clinicians in identifying the presence or absence of drugs or drug
SUBSTANCE USE/ABUSE CODING FACT SHEET FOR PRIMARY CARE CLINICIANS
SUBSTANCE USE/ABUSE CODING FACT SHEET FOR PRIMARY CARE CLINICIANS Current Procedural Terminology (CPT ) (Procedure) Codes Initial assessment usually involves a lot of time determining the differential
Clinical Assessment. Client Name (Last, First, MI) ID # Medicaid # DOB: Age:
Clinical Assessment Client Name (Last, First, MI) ID # Medicaid # DOB: Age: Sex: Ethnic Group: Marital Status: Occupation: Education: Multiaxial Diagnosis Axis I: Clinical Disorders / Other Conditions
Benzodiazepine abuse code
Search Benzodiazepine abuse code 20-10-2017 The adverse effects of benzodiazepine use and withdrawal can be remarkably similar to the impact of TEENhood trauma. Oxazepam is a short-to-intermediate-acting
Feeding and Eating Disorders
The Time is Here: Differential Diagnosis and Coding Using the DSM 5 and ICD 10 Diane Snow, PhD, RN, PMHNP-BC, FAANP, FIAAN University of Texas at Arlington College of Nursing and Health Innovation IntNSA
THE ADDICTED BRAIN: WHAT S GOING ON IN THERE? 3 CE hours. Sandra Morgenthal, PCC-S, CCFC, RN Copyright 2016 Sandra Morgenthal All rights Reserved
THE ADDICTED BRAIN: WHAT S GOING ON IN THERE? 3 CE hours Sandra Morgenthal, PCC-S, CCFC, RN Copyright 2016 Sandra Morgenthal All rights Reserved You can contact this author at sandymorgenthal@yahoo.com
substance use and mental disorders: one, the other, or both?
substance use and mental disorders: one, the other, or both? Stephen Strobbe, PhD, RN, PMHCNS-BC, CARN-AP Dawn Farm Education Series St. Joe s Education Center, Ypsilanti, MI Tuesday, January 27, 2015
Substance Use/Abuse Coding Fact Sheet for Primary Care Pediatrics
1/1/13 CPT (Procedure) Codes Substance Use/Abuse Coding Fact Sheet for Primary Care Pediatrics Initial assessment usually involves a lot of time determining the differential diagnosis, a diagnostic plan,
Clinical Assessment. Client Name (Last, First, MI) ID # Medicaid # DOB: Age: Sex: Ethnic Group: Marital Status: Occupation: Education:
Sex: Ethnic Group: Marital Status: Occupation: Education: Multiaxial Diagnosis Axis I: Clinical Disorders / Other Conditions That May Be a Focus of Clinical Attention Diagnostic Code DSM-IV Name Axis II:
A HELPFUL WALK THROUGH DSM-5
A HELPFUL WALK THROUGH DSM-5 ROGER SHAFER, MD UNITY POINT-FINLEY SUMMIT CENTER FOR OLDER ADULTS DUBUQUE, IA OBJECTIVES The learner will identify the foundational differences between the DSM-5 and the previous
Co-Occurring Mental Health and Substance Use Disorders. DATE: 11/14/2017 PRESENTED BY: John Mahan, MD
Co-Occurring Mental Health and Substance Use Disorders DATE: 11/14/2017 PRESENTED BY: John Mahan, MD Disclosure Information Speaker: John Mahan, MD has nothing to disclose Learning Objectives Understand
RSCI302 Drugs, Brain and Behavior
RSCI302 Drugs, Brain and Behavior Master Course Syllabus Course Overview (QM Standards 1.2) Course Description: The class will serve as an introduction to neuroscience and pharmacology of the central neural
Michael Schulte-Markwort / Kathrin Marutt / Peter Riedesser (Eds.) Cross-walks ICD-10 DSM-IV-TR
Michael Schulte-Markwort / Kathrin Marutt / Peter Riedesser (Eds.) Cross-walks ICD-10 DSM-IV-TR Michael Schulte-Markwort Kathrin Marutt Peter Riedesser (Editors) Cross-walks ICD-10 DSM IV-TR A Synopsis
Provider Bulletin Philadelphia Department of Behavioral Health Community Behavioral Health State Allowable ICD-9-CM Codes.
Provider Bulletin 07-01 Philadelphia Department of Behavioral Health Community Behavioral Health State Allowable ICD-9-CM Codes. February 12, 2007 The Commonwealth of Pennsylvania lists the allowable ICD-9-CM
INPATIENT INCLUDED ICD-10 CODES
INPATIENT INCLUDED ICD-10 CODES MHSUDS IN 18-053 ICD-10 F01.51 Vascular Dementia With Behavioral Disturbance F10.14 Alcohol Abuse With Alcohol-Induced Mood Disorder F10.150 Alcohol Abuse With Alcohol-Induced
UNHEALTHY ALCOHOL USE SCREENING and FOLLOW-UP (ASF) HEDIS (Administrative)
UNHEALTHY ALCOHOL USE SCREENING and FOLLOW-UP (ASF) APPLICATIONS OBJECTIVE Purpose of Measure: ELIGIBLE POPULATION Which members are included? STANDARD OF CARE NCQA ACCEPTED CODES HEDIS (Administrative)
HIBBING COMMUNITY COLLEGE COURSE OUTLINE
HIBBING COMMUNITY COLLEGE COURSE OUTLINE COURSE NUMBER & TITLE: PSYC 1400: Abnormal Psychology CREDITS: 3 (3Lec 0 / Lab) PREREQUISITES: PSYC 1205: General Psychology CATALOG DESCRIPTION: Abnormal Psychology
Substance Use Disorders. A Major Problem. Defining Addiction 2/24/2009. Lifetime rates of alcoholism estimated at 13.4 %
Substance Use Disorders A Major Problem Lifetime rates of alcoholism estimated at 13.4 % Rates of drug abuse estimated at 6% Marijuana is most frequent Approximately 600,000 deaths each year from substance
Co-Occurring Mental Health and Substance Use Disorders. DATE: 4/17/18 PRESENTED BY: John Mahan, MD
Co-Occurring Mental Health and Substance Use Disorders DATE: 4/17/18 PRESENTED BY: John Mahan, MD Disclosure Information Speaker: John Mahan, MD has nothing to disclose Planning Committee: The members
7 DSM Codes. CARE System April 2013 DSM Codes 7-1
7 DSM Codes This section contains codes and decode values used in CARE from the current edition of the and Statistical Manual of Mental Disorders. There is also an Axis (Axis 1, Axis 2, or Blank for both)
FY 2017 ICD-10-CM Code Updates
FY 2017 ICD-10-CM Code Updates Webinar I Presented by: Melanie Endicott, MBA/HCM, RHIA, CHDA, CDIP, CCS, CCS-P, FAHIMA AHIMA- Approved ICD-10-CM/PCS Trainer Senior Director, HIM Practice Excellence, AHIMA
Pamphlet Appendix 8 - ICD10 and ICD9 Crosswalk Adult Child Both. ICD9 Code
Pamphlet 155-2 Appendix 8 - ICD10 and Crosswalk Description Z63.31 Absence of family member due to military deployment M B V61.8 Other Specified Family Circumstances F55.0 Abuse of antacids S B 305.90
Bulimia Nervosa 3/12/15. Avoidant/Restrictive Food Intake Disorder. Anorexia Nervosa
Avoidant/Restrictive Food Intake Disorder Renamed from Feeding Disorder of infancy or early childhood Renamed to better capture and diagnose what was previously diagnosed as eating disorder NOS Anorexia
FAA Policy and Regulations. Agenda
FAA Policy and Regulations Presented to: 4 th Annual Aerospace Psychology Seminar By: Penny Giovanetti, D.O., MSPH Date: September 17, 2016 Agenda Safety of the National Air Space Medical Certification
Goal: To recognize and differentiate different patterns of behavior that show evidence of addiction and inadequate impulse-control
Goal: To recognize and differentiate different patterns of behavior that show evidence of addiction and inadequate impulse-control Addiction and Impulse-Control Bad behavior versus sick behavior Is bad
Anxiety Coding Fact Sheet for Primary Care Pediatrics
01/01/2017 Anxiety Coding Fact Sheet for Primary Care Pediatrics Current Procedural Terminology(CPT ) Codes Initial assessment usually involves a lot of time determining the differential diagnosis, a diagnostic
Controlled Substance Monitoring and Drugs of Abuse Testing Determination
CPT s: 80305 Drug test(s), presumptive, any number of drug classes, any number of devices or procedures (eg, immunoassay); capable of being read by direct optical observation only (eg, dipsticks, cups,
Clinical Evaluation: Assessment Goals
Clinical Evaluation: Assessment Goals 1. Define Assessment Process 2. Identify Assessment Instruments 3. Define DSM-5 criteria for Substance Abuse and Dependence, specifiers and multi-axial assessment
Introduction to DSM-5
Changes in the Diagnostic and Statistical Manual of Mental s that Impact Forensic Psychology Kristine M. Jacquin, Ph.D. Fielding Graduate University Presented at ACFP Symposium 2014 Overview of Presentation
What Clergy Need To Know. Deacon Dan Giblin, CRS
What Clergy Need To Know Deacon Dan Giblin, CRS Who am I? Husband and Father Deacon of the Archdiocese of Philadelphia, ordained in 2011 Assigned to St. Ann Parish, Phoenixville Admissions board of St.
Main Questions. Why study addiction? Substance Use Disorders, Part 1 Alecia Schweinsburg, MA Abnromal Psychology, Fall Substance Use Disorders
Substance Use Disorders Main Questions Why study addiction? What is addiction? Why do people become addicted? What do alcohol and drugs do? How do we treat substance use disorders? Why study addiction?
Organic Mental Disorders. Organic Mental Disorders. Axes. Damrongsak Bulyalert Department of Internal Medicine
Organic Mental Disorders Damrongsak Bulyalert Department of Internal Medicine www.metadon.net 1 Organic Mental Disorders In DSM (Diagnostic and Statistical Manual of Mental Disorders), OMD includes Delirium,
VALID AXIS DSM 5 CODICD 10 DESCRIPTOR BOTH R69 Diagnosis deferred BOTH Z0389 Encounter for observation for other suspected diseases and conditions
VALID AXIS DSM 5 CODICD 10 DESCRIPTOR BOTH R69 Diagnosis deferred BOTH Z0389 Encounter for observation for other suspected diseases and conditions ruled out 1 E669 Obesity, unspecified 1 F0150 Vascular
FAA Medical Certification
FAA Medical Certification 5 th Annual Aerospace Psychology Seminar Sept 23, 2017 Denver, CO Presented to: AME Seminar By: Courtney Scott, DO, MPH Date: 1 November 2012 Aerospace Medical Certification Division
Alcohol & Drug Use: Roadmap to Certification
Alcohol & Drug Use: Roadmap to Certification Daniel Danczyk, MD, MPH HIMS Psychiatrist / AME / ANG FS / Private Pilot Civil Aviation Medical Association Annual Meeting, Greensboro September 15, 2017 2016
Table of Contents VOLUME 1
VOLUME 1 A Accidents and Injuries from Alcohol... 1 Accidents and Injuries from Drugs..... 4 Addiction: Concepts and Definitions... 7 Addictive Personality............... 12 Adolescents, Drug and Alcohol
9/17/2013 EVOLUTION OF THE DSM. The Future is Now: DSM-5. The American Psychiatric Association is not. Copyright Statement
The Future is Now: DSM-5 Jason J. Washburn, PhD., ABPP Center for Evidence-Based Practice American Psychiatric Association Copyright Statement DSM and DSM-5 are registered trademarks of the American Psychiatric
Substance Use/Abuse Coding Fact Sheet for Primary Care Pediatrics
1/1/2017 Substance Use/Abuse Coding Fact Sheet for Primary Care Pediatrics Current Procedural Terminology (CPT ) Codes Initial assessment usually involves a lot of time determining the differential diagnosis,
Psychotic disorders Dr. Sarah DeLeon, MD PGYIV, Psychiatry ConceptsInPsychiatry.com
Psychotic disorders Dr. Sarah DeLeon, MD PGYIV, Psychiatry ConceptsInPsychiatry.com Introduction Psychotic spectrum disorders include schizotypal personality disorder, delusional disorder, brief psychotic
Substance use and addictive disorders in DSM-5 and ICD 10 and the draft ICD 11
REVIEW C URRENT OPINION Substance use and addictive disorders in DSM-5 and ICD 10 and the draft ICD 11 John B. Saunders a,b Purpose of review The present review compares and contrasts the diagnostic entities
The neurocognitive disorders (NCDs) (referred to in DSM-IV as "Dementia, Delirium, Amnestic, and Other Cognitive Disorders") begin with delirium,
The neurocognitive disorders (NCDs) (referred to in DSM-IV as "Dementia, Delirium, Amnestic, and Other Cognitive Disorders") begin with delirium, followed by the syndromes of major NCD, mild NCD, and their
SCID-I Version 2.0 (for DSM-IV) Non-Alcohol Use Disorders
SCID-I Version 2.0 (for DSM-IV) Non-Alcohol Use Disorders *NON-ALCOHOL SUBSTANCE USE DISORDERS* (LIFETIME DEPENDENCE AND ABUSE) Now I am going to ask you about your use of drugs or medicines. SHOW DRUG
The Impact of Substance Use Disorders on Hospital Use
www.ccsa.ca www.cclt.ca The Impact of Substance Use Disorders on Hospital Use Technical Report November 2014 Matthew M. Young, PhD Senior Research and Policy Analyst, Canadian Centre on Substance Abuse
Research Protocol for REAP Bipolar Disorder (REAP-BD)
Research Protocol for REAP Bipolar Disorder (REAP-BD) Summary REAP-BD survey will focus on the prescription patterns on bipolar disorder. Both inpatients and outpatients with bipolar disorder will be enrolled.
Psychotropic Drugs 0, 4-
0, 4- } -v Psychotropic Drugs NORMAN L. KELTNER, Ed D, RN Associate Professor, Graduate Program, University of Alabama School of Nursing, University of Alabama at Birmingham, Birmingham, Alabama DAVID
FOLLOW-UP CARE FOR CHILDREN PRESCRIBED ADHD MEDICATION (ADD) To ensure child members who are newly prescribed attentiondeficit/hyperactivity
FOLLOW-UP CARE FOR CHILDREN PRESCRIBED ADHD MEDICATION (ADD) APPLICATIONS OBJECTIVE Purpose of Measure: ELIGIBLE POPULATION Which members are included? STANDARD OF CARE NCQA ACCEPTED CODES DOCUMENTATION
SCID-I (for DSM-IV-TR) Current MDE (JAN 2007) Mood Episodes A. 5
SCID-I (for DSM-IV-TR) Current MDE (JAN 2007) Mood Episodes A. 5 Did this begin soon after someone close to you died? E. Not better accounted for by bereavement, i.e., after the loss of a loved one, the
Lecture Outline Definitions Psychoactive Substances Epidemiology Assessment Etiological Models Treatment Stages of Change
Substance-Related Disorders Cornelia Pinnell, Ph.D. Argosy University/Phoenix Lecture Outline Definitions Psychoactive Substances Epidemiology Assessment Etiological Models Treatment Stages of Change Substances
A Handbook on Drug and Alcohol Abuse
A Handbook on Drug and Alcohol Abuse THE BIOMEDICAL ASPECTS THIRD EDITION Gail Winger Frederick G. Hofmann James H. Woods New York Oxford OXFORD UNIVERSITY PRESS 1992 1. Introduction 3 The Problem of Drug
6. Describe relevant outcome criteria for evaluating nursing care of clients with substance-use
BAPTIST HEALTH SCHOOL OF NURSING NSG 3037: PSYCHIATRIC-MENTAL HEALTH NURSING THERAPEUTIC INTERVENTION AND RESOURCE MANAGEMENT: SUBSTANCE ABUSE, CODEPENDENCY, AND IMPAIRED NURSE Sheryl F. Banak, MSN, RN
BEHAVIORAL HEALTH SERVICES
BEHAVIORAL HEALTH SERVICES UnitedHealthcare Oxford Administrative Policy Policy Number: BEHAVIORAL 021.20 T0 Effective Date: October 1, 2017 Table of Contents Page INSTRUCTIONS FOR USE... 1 CONDITIONS
Mental Health CDI Review
Mental Health CDI Review AAPC April 2016 Agenda Agenda Discuss LCDs quickly Discuss Chapter 5 Documentation goals Psychiatric Diagnosis Comorbid conditions 1 LCDs Local coverage determinations Medicare
Male Sexual Dysfunction in Psychiatric Illnesses Sujit Kumar Kar 1, Saranya Dhanasekaran 1 Correspondence: gmail.
RESEARCH ARTICLE Open Access Male Sexual Dysfunction in Psychiatric Illnesses Sujit Kumar Kar 1, Saranya Dhanasekaran 1 Correspondence: drsujita@gmail.com; saranya296@ gmail.com Full list of author information
1 Cannabis problems in context: understanding increasing in treatment demand
1 Cannabis problems in context: understanding increasing in treatment demand 1.1 Demand for treatment for cannabis use 1.1.1 Proportion of clients with primary cannabis problems Cannabis can be found as
BAPTIST HEALTH SCHOOL OF NURSING NSG 3036A: PSYCHIATRIC-MENTAL HEALTH
BAPTIST HEALTH SCHOOL OF NURSING NSG 3036A: PSYCHIATRIC-MENTAL HEALTH THERAPEUTIC INTERVENTION AND RESOURCE MANAGEMENT: SUBSTANCE RELATED DISORDERS: CO-DEPENDENCY AND THE IMPAIRED NURSE LECTURE OBJECTIVES:
Polysubstance Use & Medication-Assisted Treatment
Polysubstance Use & Medication-Assisted Treatment DSM-V eliminated polysubstance disorder, instead specifying each drug of abuse and dependence. Substance-use disorder is a combination of the two DSM-IV
distinguish between structural isomers (but not necessarily stereoisomers), including, but not
CPT s: 80305 Drug test(s), presumptive, any number of drug classes, any number of devices or procedures (eg, immunoassay); capable of being read by direct optical observation only (eg, dipsticks, cups,
SCID-I (for DSM-IV-TR) Posttraumatic Stress (JAN 2007) Anxiety Disorders F. 25
SCID-I (for DSM-IV-TR) Posttraumatic Stress (JAN 2007) Anxiety Disorders F. 25 *POSTTRAUMATIC STRESS * Sometimes things happen to people that are extremely upsetting--things like being in a life threatening
ADDICTIONS. Mine Özmen, M.D. University of İstanbul Cerrahpaşa School of Medicine Department of Psychiatry
ADDICTIONS Mine Özmen, M.D. University of İstanbul Cerrahpaşa School of Medicine Department of Psychiatry Addictions-terminology drug abuse drug dependence drug addiction intoxication withdrawal tolerance
Training and Education Course Catalog. Volume 2018, No. 1
Training and Education Course Catalog Volume 2018, No. 1 Table of Contents Welcome...4 About This Catalog...4 How To Access Our Programs... 5 Relias E-Learning... 5 Continuing Education Information...6
Injuries At A Glance Emergency Department (ED) Visits for Prescription Drug Misuse
Injuries At A Glance Emergency Department (ED) Visits for Prescription Drug Misuse Last Updated: August 2016 Highlights Since 2002, the ED visits rates for prescription opioid misuse in Durham Region females
SPAMIS Medical Separation Codes for Job Corps Centers
SPAMIS Medical Separation Codes for Job Corps Centers CODE DESCRIPTION/DIAGNOSIS 1 Infectious & Parasitic Diseases 11 Pulmonary Tuberculosis 33 Pertussis 36.2 Meningococcemia 42 AIDS 47.9 Viral Meningitis
Monitored Anesthesia Care (MAC)
Monitored Anesthesia Care (MAC) Noridian Healthcare Solutions, LLC Please Note: This is a Proposed LCD. Proposed LCDs are works in progress and not necessarily a reflection of the current policies or practices.
Mental Health Nursing: Substance-Related Disorders. By Mary B. Knutson, RN, MS, FCP
Mental Health Nursing: Substance-Related Disorders By Mary B. Knutson, RN, MS, FCP History of Psychoactive Substances Used by people in almost all cultures since prehistoric times Produce effects in the
Chapter 38 Substance Abuse and Eating Disorders
Chapter 38 Substance Abuse and Eating Disorders Substance Abuse Introduction Variety of reasons for substance use o Depressed mood o Pain o Fear o Anxiety o Boredom Signs of problems when substance are
Xyrem (Sodium Oxybate)
Texas Prior Authorization Program Clinical Criteria Drug/Drug Class Clinical Criteria Information Included in this Document Drugs requiring prior authorization: the list of drugs requiring prior authorization
Substance Induced Psychosis
Substance Induced Psychosis ABSTRACT When patients present with signs of psychosis, it is critical that health clinicians are able to properly assess and determine root cause. A diagnosis of substance-induced
Neuroscience of Psychoactive Substance Use and Dependence Joint Publication of PAHO and OAS/CICAD
Neuroscience of Psychoactive Substance Use and Dependence Joint Publication of PAHO and OAS/CICAD Ms. Laura Anne Krech, MPH Technical Officer on Alcohol and Substance Abuse Pan American Health Organization
7/3/2013 ABNORMAL PSYCHOLOGY SEVENTH EDITION CHAPTER ELEVEN CHAPTER OUTLINE. Substance Use Disorders. Oltmanns and Emery
ABNORMAL PSYCHOLOGY SEVENTH EDITION Oltmanns and Emery PowerPoint Presentations Prepared by: Ashlea R. Smith, Ph.D. This multimedia and its contents are protected under copyright law. The following are
CHD 110 PSYCHOPHARMACOLOGY AND SUBSTANCE ABUSE
CHD 110 PSYCHOPHARMACOLOGY AND SUBSTANCE ABUSE PRESENTED AND APPROVED: DECEMBER 7, 2012 EFFECTIVE: FALL 2013-14 Prefix & Number CHD 110 Purpose of this submission: Change course title to reflect current
Pattern of Substance Use: Study in a De-addiction Clinic Mohammad Muntasir Maruf 1 *, Muhammad Zillur Rahman Khan 2 and Nasim Jahan 3 1
original article Oman Medical Journal [2016], Vol. 31, No. 5: 327-331 Pattern of Substance Use: Study in a De-addiction Clinic Mohammad Muntasir Maruf 1 *, Muhammad Zillur Rahman Khan 2 and Nasim Jahan
Cannabis trends in France TDI data
Cannabis trends in France TDI data Tanja Bastianić High risk drug use and drug treatment in Europe 2014 Lisbon, September 2014 Cannabis in general population in France 2 2 Cannabis in France Cannabis is
MEDICARE LOCAL COVERAGE DETERMINATION COMMONLY USED DIAGNOSIS CODES
MEDICARE LOCAL COVERAGE DETERMINATION COMMONLY USED DIAGNOSIS CODES Urine drug testing (UDT) provides objective information to assist clinicians in identifying the presence or absence of drugs or drug
SWK 3805: Module 2- Introducing Theories of Addiction
SWK 3805: Module 2- Introducing Theories of Addiction SWK 3805: Module 2- Introducing Theories of Addiction DR. AUDREY BEGUN SWK 3805: Module 2- Introducing Theories of Addiction by Dr. Audrey Begun is
DSM-5 Has Arrived Copyright 2013 Neuroscience Education Institute. All rights reserved.
Handout for the Neuroscience Education Institute (NEI) online activity: DSM-5 Has Arrived Learning Objectives Describe the major changes made to the DSM between DSM-IV and DSM-5, including manualwide changes
Mental Disorders with Associated Harmful Behavior and Substance-Related Disorders
Mental Disorders with Associated Harmful Behavior and Substance-Related Disorders Kishore Desagani, MD General Adult and Forensic Psychiatrist Consultant Psychiatrist Medical Assessment and Policy Team
DISCLAIMER: ECHO Nevada emphasizes patient privacy and asks participants to not share ANY Protected Health Information during ECHO clinics.
DISCLAIMER: Video will be taken at this clinic and potentially used in Project ECHO promotional materials. By attending this clinic, you consent to have your photo taken and allow Project ECHO to use this
What is the DSM. Diagnostic and Statistical Manual of Mental Disorders Purpose
DSM 5 The Basics What is the DSM Diagnostic and Statistical Manual of Mental Disorders Purpose Standardize diagnosis criteria (objectivity) Assist in research Provide common terminology Public health statistics
EATING DISORDERS AND SUBSTANCE ABUSE. Margot L. Waitz, DO October 7, 2017 AOAAM - OMED
EATING DISORDERS AND SUBSTANCE ABUSE Margot L. Waitz, DO October 7, 2017 AOAAM - OMED OBJECTIVES Review criteria for diagnosis of several eating disorders Discuss co-morbidity of substance abuse in patients
THE BASICS OF ADDICTION COUNSELING: DESK REFERENCE
THE BASICS OF ADDICTION COUNSELING: DESK REFERENCE MODULE I: THE PHARMACOLOGY OF PSYCHOACTIVE SUBSTANCE USE DISORDERS - Eleventh Edition - February 2018 NAADAC, the Association for Addiction Professionals
Exploring the Relationship Between Substance Abuse and Dependence Disorders and Discharge Status: Results and Implications
MWSUG 2017 - Paper DG02 Exploring the Relationship Between Substance Abuse and Dependence Disorders and Discharge Status: Results and Implications ABSTRACT Deanna Naomi Schreiber-Gregory, Henry M Jackson